000 01708 a2200505 4500
005 20250516101137.0
264 0 _c20130715
008 201307s 0 0 eng d
022 _a1476-5594
024 7 _a10.1038/onc.2012.275
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCittelly, D M
245 0 0 _aProgestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4.
_h[electronic resource]
260 _bOncogene
_cMay 2013
300 _a2555-64 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _a3' Untranslated Regions
650 0 4 _aAnimals
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCell Differentiation
_xdrug effects
650 0 4 _aCell Line, Tumor
650 0 4 _aFemale
650 0 4 _aGene Expression Regulation, Neoplastic
_xdrug effects
650 0 4 _aHumans
650 0 4 _aHyaluronan Receptors
_xmetabolism
650 0 4 _aKruppel-Like Factor 4
650 0 4 _aKruppel-Like Transcription Factors
_xgenetics
650 0 4 _aMice
650 0 4 _aMice, SCID
650 0 4 _aMicroRNAs
_xgenetics
650 0 4 _aProgesterone
_xpharmacology
650 0 4 _aProgestins
_xpharmacology
650 0 4 _aUp-Regulation
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aFinlay-Schultz, J
700 1 _aHowe, E N
700 1 _aSpoelstra, N S
700 1 _aAxlund, S D
700 1 _aHendricks, P
700 1 _aJacobsen, B M
700 1 _aSartorius, C A
700 1 _aRicher, J K
773 0 _tOncogene
_gvol. 32
_gno. 20
_gp. 2555-64
856 4 0 _uhttps://doi.org/10.1038/onc.2012.275
_zAvailable from publisher's website
999 _c21910583
_d21910583